Genomatica Awarded Phase II SBIR for Cellular Simulation Technology | GenomeWeb

NEW YORK, Nov. 4 (GenomeWeb News) - Computational systems biology startup Genomatica has received a two-year, $765,000 Phase II Small Business Innovation Research grant from the National Human Genome Research Institute to support development of its cellular simulation technology platform.

The company said it would use the award to integrate high-throughput experimental data, such as gene expression information, with its computer models of cellular metabolism.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.